State officials announced Tuesday that 23 life sciences companies will receive a total of nearly $20 million in tax incentives in exchange for their pledge to create over 1,100 jobs in the commonwealth this year.

Gov. Charlie Baker announced the awards during remarks at the BIO Convention. The closely-watched industry conference is being held in Boston this year, placing a global spotlight on the state’s thriving biotech cluster, which has benefited from extensive public funding over the past decade.

The tax incentives program is part of a broader life sciences economic development initiative that was launched in 2008 by then-Gov. Deval Patrick. On Wednesday, Baker is expected to sign a bill renewing the program for another five years and $500 million, including up to $150 million under the tax incentives provision.

The companies due to receive awards this year include Cambridge-based Moderna Therapeutics. The drug developer — one of just a few “unicorns,” or privately-held companies valued at over $1 billion, in the biotech industry — is aiming to add 115 jobs at a new manufacturing plant in Norwood.

Other awardees include WAVE Life Sciences in Lexington, which pledged to add 100 jobs in Lexington, and Alnylam Pharmaceuticals of Cambridge, which promised to create 110 jobs at a manufacturing facility in Norton.

Under the tax incentives program, the state can recoup money from companies that do not meet their job-creation goals.

Here’s the full list of companies that will receive awards this year, along with the dollar amounts and job-creation targets.